Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

Virtu Pharmako

Virtu Pharmako is a Sino-foreign joint venture biopharmaceutical company .
2021
11-50
Hangzhou, Zhejiang, China
  • Drug Discovery and Development
  • GLP-1 for food

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

35.13M

Last Funding Amount

35.13M

Last Funding Date

30-10-2024

Startup Stage

Early Stage

Lead Investors

Zhangkelingyi

Something missing or incorrect on this page? Help us enrich this information